Bruker (Nasdaq: BRKR) filed its 10-K on Feb. 29. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Bruker beat slightly on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue expanded and GAAP earnings per share grew significantly.

Gross margins shrank, operating margins shrank, net margins increased.

Revenue details
Bruker logged revenue of $475.1 million. The 10 analysts polled by S&P Capital IQ predicted revenue of $466.8 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $416.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $0.27. The eight earnings estimates compiled by S&P Capital IQ predicted $0.29 per share on the same basis. GAAP EPS of $0.23 for Q4 were 28% higher than the prior-year quarter's $0.18 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 43.6%, 460 basis points worse than the prior-year quarter. Operating margin was 11.0%, 310 basis points worse than the prior-year quarter. Net margin was 8.2%, 120 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $387.2 million. On the bottom line, the average EPS estimate is $0.12.

Next year's average estimate for revenue is $1.79 billion. The average EPS estimate is $0.93.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 258 members out of 273 rating the stock outperform, and 15 members rating it underperform. Among 68 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 65 give Bruker a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bruker is outperform, with an average price target of $16.56.

Over the decades, small-cap stocks, like Bruker have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.